Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
884 results
884
Total Filings
$5618.5B
Total Raised
48
424B4 Offerings
201
ATM Programs
8
PIPEs
| Date | Ticker | Sector | Type | Offer Price | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|
| Mar 23 | SMTK | Technology | Public Offering |
$0.23
floor
|
11.4M | $3M | — | SmartKem, Inc. is selling 11,365,350 common shares at $0.2303 per share in a registered direct offering to raise approximately $2.62 million for general corporate purposes. |
| Mar 23 | WPPGF | — | Public Offering | — | — | — | Barclays, BofA, Goldman Sachs, J.P. Morgan | WPP 2025 LLC is offering an unspecified aggregate principal amount of senior notes due 20__, guaranteed by WPP plc and subsidiaries, with proceeds use not disclosed in this preliminary prospectus supplement. |
| Mar 23 | STRD | — | ATM |
$135.66
floor
|
— | — | Barclays, Cantor Fitzgerald, Morgan Stanley, Stifel | STRD may sell up to $21 billion of Class A common stock through 19 sales agents via an at-the-market offering; proceeds to be used for general corporate purposes as disclosed in base prospectus. |
| Mar 23 | STRD | — | ATM |
$1000.00
floor
|
— | — | Barclays, Cantor Fitzgerald, Morgan Stanley | Stride Inc. may raise up to $2.1 billion selling 8.00% Series A Perpetual Strike Preferred Stock through an at-the-market offering via 19 sales agents, with proceeds for general corporate purposes. |
| Mar 23 | INBS | Healthcare | Public Offering |
$3.43
floor
|
— | — | — | Intelligent Bio Solutions Inc. may sell up to $3,966,316 of common stock through Ladenburg Thalmann at market prices via an ATM agreement, with proceeds for general corporate purposes. |
| Mar 23 | OTLK | Healthcare | Public Offering | — | — | — | — | # OTLK 424B5 - Offering Summary Outlook Therapeutics is conducting a registered direct offering of common stock with common warrants (and alternative pre-funded warrants), exercisable in five years, with proceeds intended for working capital and general corporate purposes. **Note:** Specific numbers are redacted in this preliminary prospectus supplement dated March |
| Mar 23 | APGE | Healthcare | Public Offering |
$66.04
floor
|
— | — | Jefferies, Cowen, Stifel | Apogee Enterprises (APGE) is offering $300 million of voting common stock on Nasdaq at an undisclosed price per share, with proceeds for general corporate purposes. |
| Mar 23 | IMNN | Healthcare | ATM | — | — | — | — | Imunon Inc. is selling up to $17,000,000 of common stock through an at-the-market offering with H.C. Wainwright & Co., with $4,797,848 already sold; proceeds for general corporate purposes. |
| Mar 23 | PGR | Financial Services | Public Offering | — | — | — | Goldman Sachs | # Progressive Corporation (PGR) - 424B5 Filing Progressive Corporation is offering two series of senior unsecured notes with unspecified principal amounts and interest rates; proceeds will be used for general corporate purposes. **Note:** This filing is incomplete with critical terms (amounts, rates, maturity dates, pricing) left blank, preventing precise specification of offering details. |
| Mar 23 | STRD | — | ATM | — | — | — | Barclays, Cantor Fitzgerald, Morgan Stanley | Stride Bank can sell up to $21 billion of Variable Rate Series A Perpetual Stretch Preferred Stock through 19 agents at prices to be determined, with proceeds for general corporate purposes. |
| Mar 23 | INTS | Healthcare | ATM |
$5.98
floor
|
— | — | — | Intensity Therapeutics (INTS) is increasing its at-the-market offering to $60 million in common stock via H.C. Wainwright; prior sales totaled $12.03 million from 1.29 million shares. |
| Mar 20 | GXAI | Technology | ATM |
$2.00
floor
|
3.1M | $5600.0B | — | Gaxos.ai Inc. is selling up to $1,065,001 of common stock at $1.38 per share through an at-the-market offering with H.C. Wainwright & Co., LLC as sales agent. |
| Mar 20 | UMAC | Financial Services | Public Offering |
$17.00
floor
|
8.8M | $150M | — | Unusual Machines, Inc. is selling 8,823,529 shares of common stock at $17.00 per share, raising approximately $150 million, with net proceeds of $139.5 million after 7% placement agent fees. |
| Mar 20 | UCAR | Consumer Cyclical | Public Offering |
$0.45
floor
|
— | — | — | U Power Limited is raising $5.99 million by selling 13.36 million units at $0.449 per unit; each unit includes one Class A share and one warrant with reset pricing and cashless exercise options. |
| Mar 20 | GRDN | Healthcare | Secondary |
$33.91
floor
|
— | — | BofA, Jefferies, Oppenheimer | Guardian Pharmacy Services is raising approximately $[price not specified in excerpt] by selling 1,020,000 Class A shares, with founders selling 4,980,000 shares; proceeds fund a synthetic secondary share repurchase. |
| Mar 20 | ALMU | Technology | ATM | — | — | — | — | Aeluma, Inc. is selling up to $50 million in common stock at-the-market through Roth Capital Partners and co-agents at approximately $14.06 per share, with proceeds for general corporate purposes. |
| Mar 20 | KRRO | Healthcare | Public Offering | — | 7.7M | — | — | Selling stockholders are reselling up to 7,650,764 KRRO common shares (4.5M shares plus 3.1M warrant-exercisable shares) from March 2026 private placement; company receives no proceeds except nominal $0.001 per warrant exercise. |
| Mar 19 | RVPH | Healthcare | Public Offering |
$1.50
floor
|
6.3M | $9M | — | RevPhar Pharma (RVPH) is offering 6,283,334 common shares at $1.50 each with accompanying warrants, raising approximately $9.4 million for general corporate purposes. |
| Mar 19 | GNLX | Healthcare | ATM | — | — | — | Cowen | Genlantian Limited (GNLX) is selling up to $100 million in common stock at-the-market through TD Securities, with proceeds for general corporate purposes and commission capped at 3%. |
| Mar 19 | SABSW | — | Public Offering | — | 19.3M | — | Jefferies, UBS, Citigroup, Barclays | Synthetic Biologics (SABS) is offering 19.3 million common shares and 2.75 million pre-funded warrants at $3.85/$3.8499 per share/warrant, raising approximately $85 million gross for general corporate purposes. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →